AB Cube provides drug safety and multivigilance solutions tailored to various scales, from pharmaceuticals to biotechnology firms. It offers a cloud-based pharmacovigilance software, SafetyEasy®, for managing operational compliance.

AB Cube

Pharmaceutical Manufacturing

SafetyEasy® Suite

AB Cube | 1,588 followers on LinkedIn. Since 2006, we&#39;re making safety easy with our cloud-based drug safety solution. | AB Cube fulfils vigilance requirements of every scale and scope, from research centres to prominent pharmaceutical leaders and emerging biotechnology firms. We provide patient safety and multivigilance solutions tailored to your needs.

To address the challenges of international safety regulations including combination product reporting, through SafetyEasy® Suite we offer a wide range of dedicated solutions like pharmacovigilance, medical device safety, biovigilance, nutrivigilance and CosmEthics® for cosmetovigilance.

Life Sciences Sales Executive | Strategy Consulting | Team Builder | CRM | Veteran

John Cheevers

Project Manager at AB Cube

Raphaëlle Courtay

Support Level II Developer

Aude D.

Account Manager & Sales U.S

Rayenne Bechia

Live at World Drug Safety Congress Americas in Boston! Engaging with customers and prospects, all on the same journey: to make safety easy. If you did not have a chance yet to meet with John Cheevers , you still have time to catch him there and discuss your PV projects. If you are looking to enhance compliance and reduce manual processes in your daily PV operations, discover our SafetyEasy® Suite and Galaxy modules. #WDSCAmericas #MakingSafetyEasy #pharmacovigilance #drugsafety #AI #automation

NEW AI FAQ: Since we launched our next-AI generation Galaxy module enhancements to SafetyEasy® Suite in June, interest from our entire industry ecosystem has been extremely high. As highlighted during our recent conference attendance, customers are eager to explore our new capabilities for boosting speed, efficiency and compliance across every vigilance – spanning AI-powered modules for ICSR intake and case creation to dynamic BI dashboards.🚀 Here we provide answers to some of the Frequently Asked Questions from our network: AI TOOLS VALIDATION ❓Are your AI technologies validated to industry standards? ✅ All Galaxy modules containing AI technology are validated in accordance with ISPE GAMP® 5 – Appendix D11 (A Risk-Based Approach to compliant GxP Computerized System, Second Edition) which focuses on AI and Machine Learning. All quality documentation is available within the SafetyEasy® Suite Document Management System (DMS) to assist with preparation for audits from relevant Health Authorities. AI ACT ❓Does your technology fall within the scope of the EU Artificial Intelligence Act? ✅ According to EU AI Act, the risk classification of our AI systems is classified as “minimal or no risk”. AB Cube’s AI tools therefore fall outside of the current scope of obligations under the EU AI Act. ROBUSTNESS & SECURITY ❓How robust and secure are AB Cube’s AI modules? ✅ All of the AI tools in the AB Cube Galaxy are continuously monitored to ensure that each AI system performs as per its intended use. The AI systems are continually tested for data quality, and our AI tools are fully compliant with GDPR regulations – with no customer data stored by the AI system. More questions? For further information, download our Galaxy modules brochure (🔗 https://lnkd.in/geNS4qKD ) or reach out to your AB Cube sales representative🤝 #MakingSafetyEasy #pharmacovigilance #drugsafety #AI #automation

UPCOMING: Our head of US Business Development John Cheevers will be attending World Drug Safety Congress Americas next week (October 29th - 30th, Boston)!💊 John will be at show ready to learn more about your organization's PV challenges, and demonstrate how SafetyEasy® Suite and our new Galaxy modules can empower your team to: 🔹Simplify & speed up case intake 🔹Gain case creation efficiency 🔹Enhance case analytics 🔹Improve signal detection 🔹Automate ICSR processing 🔹Boost compliance To book a meeting with John at the show, email sales@ab-cube.com See you in Boston! #WDSCAmericas #MakingSafetyEasy #pharmacovigilance #drugsafety #AI #automation

NEW: Our Autumn newsletter is out now! 🍂 Head to our website to read our latest issue, featuring: 🔹 AB Cube company news - introducing our new CCO 🔹New customer success stories - Air Liquide and Septodont 🔹Key regulatory developments in Europe & North America 🔹Autumn conference event review 🔹Brand-new downloads: Galaxy next-gen AI modules overview & Medical Device Safety Database brochure Read it online🔗 https://lnkd.in/eN6H-A7R #MakingSafetyEasy #pharmacovigilance #drugsafety #AI #automation

NEW: Our new AB Cube Galaxy brochure is now live!🌌 Download it here:🔗 https://lnkd.in/ejJ7bcFU Discover how your organization can reduce manual processes and enhance efficiency, compliance and signal detection with our next-AI gen Galaxy modules – available as add-ons to our industry-leading SafetyEasy® multivigilance suite. SafetyEasy® Suite empowers your safety team to: 🔹Simplify & speed up case intake 🔹Gain case creation efficiency 🔹Enhance case analytics 🔹Improve signal detection 🔹Automate ICSR processing 🔹Seamless system connectivity 🔹Boost compliance Check out our new brochure today and explore how our new Galaxy modules can enrich your SafetyEasy® multivigilance platform with enhanced efficiency and compliance. #MakingSafetyEasy #pharmacovigilance #drusgsafety #AI #automation

We’re live at #WDSCE with our innovative pharmacovigilance software and AI-driven modules that are already transforming the daily workflows of our users. Come visit us at booth 22, and discover how we’re leading the way in automation, integration, and ease of use. Let’s chat about how we can enhance your processes and make your work smoother! Looking forward to seeing you! 👋 #Pharmacovigilance #Innovation #AI #Automation #Event

As the first day of conferences and gatherings is coming to an end, we've picked our prize draw winner! Same game, same prize, same booth tomorrow! #makingsafetyeasy #pharmacovigilance

AB Cube team is waiting for you booth 22! #WDSCE #makingsafetyeasy #pharmacovigilance

Metric
Company Name	AB Cube
Symbol
MSH ID	COM:AB-CUBE
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals
Country	DE
Stage
Employee Count
Website	ab-cube.com
LinkedIn	ab-cube
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

AB-C

COM:AB-CUBE

AB Cube

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue